Search
for
Sort by
Research 781–810 of 1000+
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Health Care System
- Letter to the Editor: A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Healthcare System
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- JAK Inhibitor Baricitinib in the Treatment of Oral Lichen Planus: A Case Report
- Alopecia Areata: JAK Inhibitors—PRP and Exosomes
- JAK UZYSKAĆ PRAWO PRACY JAKO LEKARZ W POLSCE, KWESTIA EGZAMINU JĘZYKOWEGO. PARADOKS POMIĘDZY BRAKAMI W ZAWODACH MEDYCZNYCH, A DOSTĘPEM DO ZAWODU LEKARZA W POLSCE DLA LEKARZY, KTÓRZY NIE STUDIOWALI W POLSCE
- 59 Scarring alopecia is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
- 84 Partial restoration of scalp microbiota in alopecia areata with JAK inhibitors
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Scarring hair follicle destruction is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- 43647 Treatment of Refractory Folliculitis Decalvans with the Topical JAK Inhibitor Tofacitinib
- JAK inhibitor deuruxolitinib shows encouraging hair re-growth in alopecia areata
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- The Triumph of JAK Inhibitors for the Treatment of Alopecia Areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Komplet remission ved behandling med JAK-hæmmer hos en patient med alopeciatotalis
- JAK inhibitors for the treatment of alopecia areata
- 706 Predictive modeling of patient response to JAK/STAT inhibitors and dynamic patient-matching
- 1359 Hair growth is induced by blockade of macrophage-derived oncostatin M and downstream JAK-STAT5 signaling in hair follicle stem cells
- 865 Conditional ablation of JAK-STAT5 signaling induces anagen hair growth
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- 546 Gene expression signatures and ALADIN score correlates with response of alopecia areata patients to treatment with JAK inhibitors
- Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?
- Selective JAK 1 inhibition with upadacitinib as a potential treatment for coexistent severe atopic dermatitis and alopecia areata
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis